KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Non-Current Assets: 2018-2025

Historic Non-Current Assets for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $308.9 million.

  • Twist Bioscience's Non-Current Assets rose 15.45% to $308.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $308.9 million, marking a year-over-year increase of 15.45%. This contributed to the annual value of $308.9 million for FY2025, which is 15.45% up from last year.
  • According to the latest figures from FY2025, Twist Bioscience's Non-Current Assets is $308.9 million, which was up 15.45% from $267.5 million recorded in FY2024.
  • In the past 5 years, Twist Bioscience's Non-Current Assets ranged from a high of $364.9 million in FY2022 and a low of $155.6 million during FY2021.
  • Moreover, its 3-year median value for Non-Current Assets was $308.9 million (2025), whereas its average is $309.5 million.
  • Per our database at Business Quant, Twist Bioscience's Non-Current Assets surged by 143.08% in 2021 and then declined by 24.02% in 2024.
  • Twist Bioscience's Non-Current Assets (Yearly) stood at $155.6 million in 2021, then skyrocketed by 134.51% to $364.9 million in 2022, then dropped by 3.49% to $352.1 million in 2023, then dropped by 24.02% to $267.5 million in 2024, then rose by 15.45% to $308.9 million in 2025.